In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Stephan Windecker
Speaker
Stephan Windecker

Speciality : Interventional Cardiology

33 presentations from this speaker

Recorded Live procedure: TAVI

Congress : ESC Congress 2019

  • Session : TAVI - Transcatheter Aortic Valve Implantation
  • Speaker : S Windecker (Bern,CH)

Stable coronary disease: assessment and intervention.

Congress : ESC Congress 2019

  • Session : The European Heart Journal's advances from prevention to intervention: the year in Cardiology
  • Speaker : S Windecker (Bern,CH)
  • Joint with the European Heart Journal

Take home messages

Congress : ESC Congress 2019

  • Session : Functional mitral regurgitation in heart failure - Time to treat!
  • Speaker : S Windecker (Bern,CH)
  • Sponsored by Abbott Structural Heart

A patient with functional mitral regurgitation - Wrap-up and take home message

Congress : Heart Failure 2018

  • Session : Guidelines in daily practice III - Valvular disease
  • Speaker : S Windecker (Bern,CH)

Atrial fibrillation patients who develop acute coronary syndrome: Is there a role for aspirin?

Congress : ESC Congress 2018

  • Session : Atrial fibrillation patients who develop acute coronary syndrome: is there a role for aspirin?
  • Speaker : R Lopes (Durham,US), S Windecker (Bern,CH), S Halvorsen (Oslo,NO)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Choosing between TAVI and surgery: challenges and current strategies

Congress : ESC Congress 2018

  • Session : Aortic stenosis treatments? I know it all! - You will be surprised..
  • Speaker : S Windecker (Bern,CH)
  • Sponsored by Medtronic

Discussant review - MITRA.fr.

Congress : ESC Congress 2018

  • Session : Hot Line Session 3
  • Speaker : S Windecker (Bern,CH)

New developments in transcatheter treatment of valvular heart disease.

Congress : ESC Congress 2018

  • Session : 2018 update in interventional cardiology
  • Speaker : S Windecker (Bern,CH)
  • European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Percutaneous interventions

Congress : Heart Failure 2018

  • Session : Tricuspid valve - Challenges and opportunities
  • Speaker : S Windecker (Bern,CH)

Revascularisation in stable CAD is useful - PRO

Congress : ESC Congress 2018

  • Session : Revascularisation in stable CAD: the Holy Grail or overused?
  • Speaker : S Windecker (Bern,CH)
  • Great Debate

Revascularisation in stable CAD is useful - Rebuttal PRO

Congress : ESC Congress 2018

  • Session : Revascularisation in stable CAD: the Holy Grail or overused?
  • Speaker : S Windecker (Bern,CH)
  • Great Debate

Value of MitraClip in reducing burden of FMR.

Congress : ESC Congress 2018

  • Session : Transcatheter mitral valve repair in functional mitral regurgitation : time for evidence!
  • Speaker : S Windecker (Bern,CH)
  • Sponsored by Abbott

Valve durability after transcatheter aortic valve implantation.

Congress : ESC Congress 2018

  • Session : Valve durability after transcatheter and surgical aortic valve replacement
  • Speaker : S Windecker (Bern,CH)

Diploma by the chairpersons.

Congress : ESC Congress 2017

  • Session : ESC Andreas Gr√ľntzig Lecture on Interventional Cardiology
  • Speaker : S Windecker (Bern,CH)

Revascularisation.

Congress : Heart Failure 2017

  • Session : Hot topics in diabetes and heart failure
  • Speaker : S Windecker (Bern,CH)

What is the evidence supporting the new valvular heart disease (VHD) guidelines regarding severe aortic stenosis (AS) treatment?

Congress : ESC Congress 2017

  • Session : How the new ESC clinical practice guidelines on valvular heart disease could change the treatment of patients with aortic stenosis
  • Speaker : S Windecker (Bern,CH)
  • Sponsored by Edwards Lifesciences

DOCTORS - Discussant review.

Congress : ESC Congress 2016

  • Session : Hot Line coronary artery disease and imaging
  • Speaker : S Windecker (Bern,CH)

GALILEO: Rivaroxaban in TAVR patients.

Congress : ESC Congress 2016

  • Session : The future is in the pipeline
  • Speaker : S Windecker (Bern,CH)

Invasive diagnostic approach to stable CAD should be the standard - PRO

Congress : ESC Congress 2016

  • Session : Stable coronary artery disease: stress testing thrown to the lions
  • Speaker : S Windecker (Bern,CH)

Lessons from randomised clinical trials

Congress : ESC Congress 2016

  • Session : Update on transcatheter aortic valve implantation in 2016
  • Speaker : S Windecker (Bern,CH)

Revascularisation strategies.

Congress : Heart Failure 2016

  • Session : Cardiogenic shock: how can we improve prognosis?
  • Speaker : S Windecker (Bern,CH)

TAVI: current and future perspectives for adjunctive antithrombotic therapy.

Congress : ESC Congress 2016

  • Session : Practical management of patients with atrial fibrillation - Individualized approaches to stroke prevention
  • Speaker : S Windecker (Bern,CH)
  • Sponsored by Bayer Pharma AG

Thromboembolic prevention after TAVI: antiplatelets or anticoagulants? - Conclusion

Congress : ESC Congress 2016

  • Session : Thromboembolic prevention after TAVI: antiplatelets or anticoagulants?
  • Speaker : S Windecker (Bern,CH)

Will TAVI replace surgical aortic valve replacement?

Congress : ESC Congress 2016

  • Session : Hot topics in interventional cardiology 2016
  • Speaker : S Windecker (Bern,CH)
  • Organised by European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Early TAVI complications.

Congress : Acute Cardiovascular Care 2015

  • Session : Non coronary emergencies in acute cardiovascular care
  • Speaker : S Windecker (Bern,CH)

The diabetic patient.

Congress : Acute Cardiovascular Care 2015

  • Session : Acute coronary syndromes in special populations.
  • Speaker : S Windecker (Bern,CH)

Concluding remarks.

Congress : ESC Congress 2014

  • Session : ESC/EACTS Guidelines on myocardial revascularization
  • Speaker : S Windecker (Bern,CH)

Myocardial revascularization.

Congress : ESC Congress 2014

  • Session : ESC Guidelines 2014 overview
  • Speaker : S Windecker (Bern,CH), PH Kolh (Liege,BE)

Myocardial revascularization.

Congress : ESC Congress 2014

  • Session : Meet the Guidelines Task Force I
  • Speaker : S Windecker (Bern,CH), PH Kolh (Liege,BE)

Are the fancy new devices effective in STEMI?

Congress : ESC Congress 2013

  • Session : STEMI management: the fancy and the reality
  • Speaker : S Windecker (Bern,CH)
  • Sponsored by Pfizer

FAME II: was it stopped too early?

Congress : ESC Congress 2013

  • Session : Controversies in interpreting clinical trials
  • Speaker : S Windecker (Bern,CH)

Severe aortic stenosis treated with trans aortic valve implants.

Congress : ESC Congress 2013

  • Session : Top 5 in invasive cardiology: "Why and which patient to refer"
  • Speaker : S Windecker (Bern,CH)
  • Sponsored by Medtronic

What needs to be demonstrated in future trials?

Congress : ESC Congress 2013

  • Session : Bioresorbable scaffold: the advent of a new era in percutaneous coronary revascularisation?
  • Speaker : S Windecker (Bern,CH)

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are